← Every company
Ionis Pharmaceuticals Inc SEC Filings
What Ionis Pharmaceuticals Inc has told the SEC happened, by the 8-K items and forms it filed under: when it reported results, who joined or left, what it bought or sold, and whether its auditor or its accounts ever changed.
IONS overview →Filings on file
145
since Nov 9, 2016
Warning signs
1
latest Jul 28, 2022
Last results
Jul 29, 2026
8-K item 2.02
Industry
Pharmaceutical Preparations
SIC 2834
Newest first
Each label is a form type or an 8-K item as filed; each row links to the filing.
| Filed | What it reports | Document |
|---|---|---|
| Jul 28, 2022 | Delisting notice or listing transfer 8-K | Read ↗ |
Source: Ionis Pharmaceuticals Inc's EDGAR filing history, the last ten years. The labels are the form types and 8-K item numbers the company filed under, not a reading of what it wrote — an item 5.02 can be a chief executive fired or a director retiring on schedule — so each row links to the filing.
More on IONS
Company overviewEverything on IONS in one place, with the price.Insider tradingWhat IONS's own officers and directors buy and sell.Executive payWhat IONS awarded its chief executive, and what it became.Who owns itEvery manager reporting a position in IONS.Funds holding itWhich funds and ETFs hold IONS, and how big a bet.LobbyingWhat IONS spends lobbying Congress, and on what.Who lobbies for itThe lobbyists on IONS's account, and who they worked for.PatentsWhat IONS is filing at the patent office.